Literature DB >> 23152112

Differential expression of the pro-natriuretic peptide convertases corin and furin in experimental heart failure and atrial fibrosis.

Tomoko Ichiki1, Guido Boerrigter, Brenda K Huntley, S Jeson Sangaralingham, Paul M McKie, Gail J Harty, Gerald E Harders, John C Burnett.   

Abstract

In heart failure (HF), the cardiac hormone natriuretic peptides (NPs) atrial (ANP), B-type (BNP), and C-type (CNP) play a key role to protect cardiac remodeling. The proprotein convertases corin and furin process their respective pro-NPs into active NPs. Here we define in a canine model of HF furin and corin gene and protein expression in normal and failing left atrium (LA) or ventricle (LV) testing the hypothesis that the NP proproteins convertases production is altered in experimental HF. Experimental canine HF was produced by rapid right ventricular pacing for 10 days. NPs, furin, and corin mRNA expression were determined by quantitative RT-PCR. Protein concentration or expression was determined by immunostaining, radioimmunoassay, or Western blot. Furin and corin proteins were present in normal canine LA and LV myocardium and vasculature and in smooth muscle cells. In normal canines, expression of NPs was dominant in the atrium compared with the ventricle. In experimental early stage HF characterized with marked atrial fibrosis, ANP, BNP, and CNP mRNA, and protein concentrations were higher in HF LA but not HF LV compared with normals. In LA, corin mRNA and protein expressions in HF were lower, whereas furin mRNA and protein expressions were higher than normals. NPs and furin expressions were augmented in the atrium in experimental early stage HF and, conversely, corin mRNA and protein expressions were decreased with atrial remodeling. Selective changes of these NP convertases may have significance in the regulation of pro-NP processing and atrial remodeling in early stage HF.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23152112      PMCID: PMC3543660          DOI: 10.1152/ajpregu.00233.2012

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  49 in total

1.  Quantitation of collagen in human myocardium.

Authors:  D E OKEN; R J BOUCEK
Journal:  Circ Res       Date:  1957-07       Impact factor: 17.367

Review 2.  Animal models of heart failure: a scientific statement from the American Heart Association.

Authors:  Steven R Houser; Kenneth B Margulies; Anne M Murphy; Francis G Spinale; Gary S Francis; Sumanth D Prabhu; Howard A Rockman; David A Kass; Jeffery D Molkentin; Mark A Sussman; Walter J Koch; Walter Koch
Journal:  Circ Res       Date:  2012-05-17       Impact factor: 17.367

3.  Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure.

Authors:  Adam M Hawkridge; Denise M Heublein; H Robert Bergen; Alessandro Cataliotti; John C Burnett; David C Muddiman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-17       Impact factor: 11.205

Review 4.  Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target.

Authors:  F G Spinale; M L Coker; B R Bond; J L Zellner
Journal:  Cardiovasc Res       Date:  2000-05       Impact factor: 10.787

5.  Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure.

Authors:  O Lisy; J G Lainchbury; H Leskinen; J C Burnett
Journal:  Hypertension       Date:  2001-04       Impact factor: 10.190

6.  Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart.

Authors:  W Yan; N Sheng; M Seto; J Morser; Q Wu
Journal:  J Biol Chem       Date:  1999-05-21       Impact factor: 5.157

7.  Hypertension in mice lacking the proatrial natriuretic peptide convertase corin.

Authors:  Joyce C Y Chan; Ole Knudson; Faye Wu; John Morser; William P Dole; Qingyu Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-06       Impact factor: 11.205

8.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

9.  The proprotein convertase PACE4 is upregulated by PDGF-BB in megakaryocytes: gene expression of PACE4 and furin is regulated differently in Dami cells.

Authors:  Miwa Bando; Atsushi Matsuoka; Akihiko Tsuji; Yoshiko Matsuda
Journal:  J Biochem       Date:  2002-07       Impact factor: 3.387

10.  Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure.

Authors:  A Luchner; T L Stevens; D D Borgeson; M Redfield; C M Wei; J G Porter; J C Burnett
Journal:  Am J Physiol       Date:  1998-05
View more
  25 in total

1.  Plasma corin decreases after coronary artery bypass graft surgery and is associated with postoperative heart failure: a pilot study.

Authors:  Caryn S Barnet; Xiaoxia Liu; Simon C Body; Charles D Collard; Stanton K Shernan; Jochen D Muehlschlegel; Petr Jarolim; Amanda A Fox
Journal:  J Cardiothorac Vasc Anesth       Date:  2014-11-11       Impact factor: 2.628

Review 2.  Corin in natriuretic peptide processing and hypertension.

Authors:  Yiqing Zhou; Qingyu Wu
Journal:  Curr Hypertens Rep       Date:  2014-02       Impact factor: 5.369

3.  Cardiac fibrosis in end-stage human heart failure and the cardiac natriuretic peptide guanylyl cyclase system: regulation and therapeutic implications.

Authors:  Tomoko Ichiki; John A Schirger; Brenda K Huntley; Frank V Brozovich; Joseph J Maleszewski; Sharon M Sandberg; S Jeson Sangaralingham; Soon J Park; John C Burnett
Journal:  J Mol Cell Cardiol       Date:  2014-08-09       Impact factor: 5.000

Review 4.  Role of corin in the regulation of blood pressure.

Authors:  Hui Li; Yue Zhang; Qingyu Wu
Journal:  Curr Opin Nephrol Hypertens       Date:  2017-03       Impact factor: 2.894

5.  Distinct roles of N-glycosylation at different sites of corin in cell membrane targeting and ectodomain shedding.

Authors:  Hao Wang; Tiantian Zhou; Jianhao Peng; Ping Xu; Ningzheng Dong; Shenghan Chen; Qingyu Wu
Journal:  J Biol Chem       Date:  2014-12-01       Impact factor: 5.157

6.  Salt-water imbalance and fluid overload in hemodialysis patients: a pivotal role of corin.

Authors:  Carlo Alberto Ricciardi; Antonio Lacquaniti; Valeria Cernaro; Annamaria Bruzzese; Luca Visconti; Saverio Loddo; Domenico Santoro; Michele Buemi
Journal:  Clin Exp Med       Date:  2015-07-24       Impact factor: 3.984

7.  Differential effects of low-dose sacubitril and/or valsartan on renal disease in salt-sensitive hypertension.

Authors:  Iuliia Polina; Mark Domondon; Rebecca Fox; Anastasia V Sudarikova; Miguel Troncoso; Valeriia Y Vasileva; Yuliia Kashyrina; Monika Beck Gooz; Ryan S Schibalski; Kristine Y DeLeon-Pennell; Wayne R Fitzgibbon; Daria V Ilatovskaya
Journal:  Am J Physiol Renal Physiol       Date:  2020-05-28

8.  Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides.

Authors:  Tomoko Ichiki; Brenda K Huntley; S Jeson Sangaralingham; John C Burnett
Journal:  JACC Heart Fail       Date:  2015-09       Impact factor: 12.035

Review 9.  Atrial fibrillation as manifestation and consequence of underlying cardiomyopathies: from common conditions to genetic diseases.

Authors:  Adam Mohmand-Borkowski; W H Wilson Tang
Journal:  Heart Fail Rev       Date:  2014-05       Impact factor: 4.214

10.  MANP (M-Atrial Natriuretic Peptide) Reduces Blood Pressure and Furosemide-Induced Increase in Aldosterone in Hypertension.

Authors:  Nina A Dzhoyashvili; Seethalakshmi R Iyer; Horng H Chen; John C Burnett
Journal:  Hypertension       Date:  2022-01-20       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.